NANOG and neoplasm: As CD133 has been considered to be a cancer stem cell marker in several tumor types, we examined mRNA expression of the stemness gene Oct-4, NANOG and metastasis-associated receptor CXCR4 using RT-PCR in the CD133+ population and its counterpart CD133− cells.